Portfolio (Quarterly)
Guide ↗
Opaleye Management Inc.
· CIK 0001595855| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | APOGEE THERAPEUTICS INC | — | 388,257.0 | $29.3M | 3.87% | +25K | +6.9% | $75.48 | — |
| 2 | STOK | STOKE THERAPEUTICS INC | Healthcare | 695,000.0 | $22.1M | 2.91% | +13K | +1.9% | $31.74 | -8.5% |
| 3 | SLGL | SOL GEL TECHNOLOGIES | Healthcare | 453,739.0 | $19.1M | 2.52% | +249K | +121.5% | $42.14 | +50.2% |
| 4 | — | DISC MEDICINE INC | — | 200,000.0 | $15.9M | 2.10% | +6K | +3.2% | $79.41 | — |
| 5 | RZLT | REZOLUTE INC | Healthcare | 6,287,156.0 | $14.8M | 1.96% | +5.4M | +595.9% | $2.36 | +37.3% |
| 6 | ALKS | ALKERMES PLC | Healthcare | 490,000.0 | $13.7M | 1.81% | +40K | +8.9% | $27.98 | +32.2% |
| 7 | — | ALPHA COGNITION INC | — | 2,070,784.0 | $13.5M | 1.78% | +2.0M | +1698.5% | $6.50 | — |
| 8 | MBX | MBX BIOSCIENCES INC | Healthcare | 260,000.0 | $8.2M | 1.08% | +7K | +2.8% | $31.54 | -1.8% |
| 9 | XOMA | XOMA CORP DEL | Healthcare | 292,590.0 | $7.8M | 1.03% | +38K | +14.7% | $26.59 | +56.6% |
| 10 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 70,000.0 | $3.0M | 0.40% | +32K | +85.2% | $42.83 | -33.2% |
| 11 | — | ZYMEWORKS INC | — | 108,929.0 | $2.9M | 0.38% | +9K | +8.9% | $26.33 | — |
| 12 | — | OPUS GENETICS INC | — | 1,120,000.0 | $2.3M | 0.30% | +20K | +1.8% | $2.01 | — |
| 13 | CABA | CABALETTA BIO INC | Healthcare | 900,000.0 | $2.0M | 0.26% | +91K | +11.3% | $2.19 | +49.3% |
| 14 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 1,400,906.0 | $1.9M | 0.25% | +1.1M | +342.6% | $1.35 | +168.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%